Sage Therapeutics, Inc. Marketable Securities, Current in USD from Q4 2015 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Sage Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2015 to Q2 2025.
  • Sage Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2025 was $298M, a 45.5% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Sage Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $298M -$249M -45.5% Jun 30, 2025 10-Q 2025-07-30
Q1 2025 $379M -$166M -30.4% Mar 31, 2025 10-Q 2025-04-29
Q4 2024 $423M -$259M -37.9% Dec 31, 2024 10-Q 2025-07-30
Q3 2024 $470M -$258M -35.4% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $547M -$334M -37.9% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $544M -$379M -41% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $682M -$428M -38.5% Dec 31, 2023 10-K 2025-02-11
Q3 2023 $727M -$466M -39.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $881M -$426M -32.6% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $923M -$524M -36.2% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $1.11B -$338M -23.4% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $1.19B -$227M -16% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.31B -$90M -6.44% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $1.45B +$342M +30.9% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $1.45B +$1.01B +230% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $1.42B +$937M +193% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $1.4B +$899M +180% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $1.1B +$431M +64.1% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $438M -$443M -50.3% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $484M -$379M -43.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $498M -$572M -53.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $673M -$336M -33.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $882M +$150M +20.5% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $863M +$94.8M +12.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.07B +$304M +39.6% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $1.01B +$483M +91.8% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $732M +$519M +244% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $768M +$660M +608% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $767M +$614M +403% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $526M +$329M +167% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $213M -$16.3M -7.14% Dec 31, 2017 10-K 2019-02-19
Q3 2017 $109M -$2.66M -2.39% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $152M +$69.2M +83.1% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $197M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $229M +$229M Dec 31, 2016 10-K 2018-02-22
Q3 2016 $111M Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $83.3M Jun 30, 2016 10-Q 2016-08-09
Q4 2015 $0 Dec 31, 2015 10-K 2017-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.